Literature DB >> 27125717

Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.

Muhammad Ali Khan1, Bilal Ali1, Wade M Lee2, Colin W Howden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27125717     DOI： 10.1038/ajg.2016.24

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

2.  Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.

Authors:  A Tursi; G Brandimarte; W Elisei; M Picchio; G Forti; G Pianese; S Rodino; T D'Amico; N Sacca; P Portincasa; E Capezzuto; R Lattanzio; A Spadaccini; S Fiorella; F Polimeni; N Polimeni; V Stoppino; G Stoppino; G M Giorgetti; F Aiello; S Danese
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

Review 3.  Sigmoid diverticulitis: a systematic review.

Authors:  Arden M Morris; Scott E Regenbogen; Karin M Hardiman; Samantha Hendren
Journal:  JAMA       Date:  2014-01-15       Impact factor: 56.272

4.  A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial.

Authors:  Neil Stollman; Simon Magowan; Fergus Shanahan; Eamonn M M Quigley
Journal:  J Clin Gastroenterol       Date:  2013-08       Impact factor: 3.062

5.  Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials.

Authors:  Jeffrey B Raskin; Michael A Kamm; M Mazen Jamal; Juan Márquez; Ehud Melzer; Robert E Schoen; Tibor Szalóki; Karen Barrett; Paul Streck
Journal:  Gastroenterology       Date:  2014-07-16       Impact factor: 22.682

6.  Intermittent treatment with mesalazine in the prevention of diverticulitis recurrence: a randomised multicentre pilot double-blind placebo-controlled study of 24-month duration.

Authors:  F Parente; S Bargiggia; A Prada; A Bortoli; A Giacosa; B Germanà; A Ferrari; G Casella; G De Pretis; G Miori
Journal:  Int J Colorectal Dis       Date:  2013-06-12       Impact factor: 2.571
  6 in total
  9 in total

1.  Mesalamine in Recurrent Acute Colonic Diverticulitis.

Authors:  Cong Dai; Min Jiang; Ming-Jun Sun
Journal:  Am J Gastroenterol       Date:  2016-11       Impact factor: 10.864

2.  Response to Dai et al.

Authors:  Muhammad Ali Khan; Colin W Howden
Journal:  Am J Gastroenterol       Date:  2016-11       Impact factor: 10.864

Review 3.  Drains, Germs, or Steel: Multidisciplinary Management of Acute Colonic Diverticulitis.

Authors:  Augusto Lauro; Eleonora Pozzi; Samuele Vaccari; Maurizio Cervellera; Valeria Tonini
Journal:  Dig Dis Sci       Date:  2020-09-27       Impact factor: 3.199

Review 4.  Diverticular Disease: An Update on Pathogenesis and Management.

Authors:  Mona Rezapour; Saima Ali; Neil Stollman
Journal:  Gut Liver       Date:  2018-03-15       Impact factor: 4.519

Review 5.  Inflammation management in acute diverticulitis: current perspectives.

Authors:  Marco Ceresoli; Giulia Lo Bianco; Luca Gianotti; Luca Nespoli
Journal:  J Inflamm Res       Date:  2018-05-30

Review 6.  Recent advances in understanding and managing diverticulitis.

Authors:  Carola Severi; Marilia Carabotti; Alessia Cicenia; Lucia Pallotta; Bruno Annibale
Journal:  F1000Res       Date:  2018-06-29

7.  Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.

Authors:  Andrea Iannone; Marinella Ruospo; Germaine Wong; Michele Barone; Mariabeatrice Principi; Alfredo Di Leo; Giovanni F M Strippoli
Journal:  Can J Gastroenterol Hepatol       Date:  2018-09-16

8.  Statin use and risk of acute diverticulitis: A population-based case-control study.

Authors:  Michael O'Grady; Louise Clarke; Gregory Turner; Matt Doogue; Rachel Purcell; John Pearson; Frank Frizelle
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

Review 9.  Progress and challenges in the management of diverticular disease: which treatment?

Authors:  Angel Lanas; Daniel Abad-Baroja; Aitor Lanas-Gimeno
Journal:  Therap Adv Gastroenterol       Date:  2018-07-23       Impact factor: 4.409
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.